COVID Drug Recall; Update on Nurse Struck by Lightning; Surrogates' Pregnancy Risks

— Health news and commentary gathered by staff

MedicalToday
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Note that some links may require registration or subscription.

Gilead voluntarily recalled one lot of the COVID-19 treatment remdesivir (Veklury) because a customer found a in the vial.

Novo Nordisk's CEO is scheduled to testify on Capitol Hill this morning, likely facing pushback for the high costs of . (NBC News)

Africa has faced a whopping of mpox this year. (Reuters)

Meanwhile, India reported its first case of the fast-spreading . (Reuters)

A nurse last year finally was discharged after more than a year in the hospital. (People)

Prenatal pandemic exposure and maternal SARS-CoV-2 infection were of positive autism screens in New York City. (JAMA Network Open)

The first person with in New York state in a decade died. (New York Times)

Surrogates faced a high risk of pregnancy and . (Annals of Internal Medicine)

Antihypertensive deprescribing was associated with in nursing home residents, especially those with dementia. (JAMA Internal Medicine)

Most Hispanic adults , according to a new poll. (AP)

Maternal influenza infection during pregnancy in Taiwan was tied to , but not epilepsy, in offspring. (JAMA Network Open)

Investing $0.24 on per patient each year could save 2 million lives and avert 7 million acute events in the next decade, according to a new WHO report.

Particle Health, a medical records startup, for allegedly violating U.S. antitrust law. (Reuters)

Ashwin Vasan, MD, PhD, New York City's health commissioner since 2022, is in January. (ABC7)

Lots of people , and some critics think that drugmakers and the FDA could do more. (STAT)

The American College of Physicians determined that were lacking. (Annals of Internal Medicine)

Amid growing concerns over microplastics, California accused ExxonMobil of about the effectiveness of plastic recycling. (Washington Post)